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A basic scientist’s reflections on research
funding
Katalin Szaszi1,2
Scientists are among the most enthusiastic people when
it comes to talking about their work. Despite this, it
seems that it is the funding system that Canadian scien-
tists most often discuss these days, and not their findings
and new ideas. Needless to say, research can only exist
with good and secure funding, but when obtaining fund-
ing becomes a dominant part of investigators’ activity,
the system has a problem. I am a cell biologist and
physiologist recruited to Canada from Hungary. Gener-
ous funding helped me to complete my post-doctoral
training here and to start my own lab a decade ago. The
transition from post-doc was smoothened by one of the
last Canadian Institutes of Health Research (CIHR)
Senior Research Fellowships that gave 2 years of post-
doctoral funding and 2 years of new investigator salary
support. I was extremely lucky to have this opportunity,
which is no longer available to current post-docs. How-
ever, as my independent work started to produce results,
I had to realize how difficult it was to maintain even a
modestly sized lab (one technician and two students)
within a research institute. As the reality of inevitable
rejections of first grant renewal applications set in, I was
swept away by the struggle for funding and the never-
ending cycles of reviewing. This experience, shared by
many of us, shaped my views on the ills of the Canadian
biomedical research funding system. I am sharing my
thoughts on this important and complex topic, with the
hope that it will be part of a fruitful discussion.
The struggle for funding overtakes research
There is a general agreement that the funding system for
biomedical research is broken. In fact, many researchers
would describe our current situation as a deep crisis.
Although we lack hard data to verify the darkening
mood of the science community, we seem to be losing
the creative, idea-centred environment required for
leading-edge science. A common experience of many of
us is a sense of hopelessness and bitterness due to the
non-stop struggle for funding, and the lack of fairness
and predictability in our professional lives. In fact, I have
never before witnessed such desperation among my col-
leagues during my 17 years in research in this country.
As recently pointed out by the Canadian Society for
Molecular Biosciences in a letter to the Minister of
Industry, ‘the overwhelming majority of discovery re-
search laboratories critically depend on the very com-
petitive and most innovative open operating grant
competitions’ [1]. As funding rates are falling, labs are
underfunded, and the current funding environment
threatens the existence of many labs across the country.
Even well-established investigators, who have proven
themselves excellent and productive scientists, are just
one failed renewal application away from a crisis due to
disruption in funding. High-quality research productivity
no longer guarantees renewal of funding. ‘Publish or
perish’ has been replaced by ‘publish AND perish’. As a
result, we now spend less time focusing on ideas and
research itself, and more time applying for funding. As I
learned during my many cycles of resubmissions, enor-
mous amount of resources and brain power goes into pre-
paring grants, generating preliminary data and addressing
often subjective requests from reviewers who might not
even be in the committee to read the resubmission.
The cycles of resubmissions waste financial and hu-
man resources, but in addition to this, their detrimental
effects on the psyche of all involved cannot be empha-
sized enough. I spent unimaginable number of hours re-
writing the same grant for resubmissions, time I spent
not doing research. Loss of time however was not the
biggest problem. As many of us will testify, nothing re-
duces scientific creativity more than the increasingly
desperate fight for funding, the inevitable soul-crushing
rejections, and the constant pressure from competition.
There is nothing less motivating than writing and
reviewing grants, especially with the knowledge that the
outcome more likely than not will be a rejection. The
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constant grant competitions with unpredictable outcomes
are a major source of debilitating stress that crushes cre-
ative thinking. In addition, it is worth noting that science
is a collaborative endeavour, where the rocky road towards
discovery is best smoothened by sharing data instead of
hiding them to protect one’s chances for funding. Overall,
our funding system is turning scientists into entrepreneurs
and managers, and forcing them into roles they have not
trained for, never wanted as a career, and which requires a
very different mindset than doing science. I was trained to
be a scientist and Dragon’s den is not my world. Rules of
the business world cannot be applied to science.
Training is also an important task of research labs.
The funding crunch victimizes our trainees in more than
one way. Students are facing a rapidly changing training
environment, as fewer researchers can afford to train
graduate students. Those labs that can still participate in
training now rely too heavily on these inexperienced but
cheap members of the research community to perform
cutting-edge science. Absence in the labs of senior
people, e.g. technicians and research associates who no
longer can be paid from average grants, reduces the
quality of both training and research, slows progress,
and forces students into roles they often cannot fulfil.
This is a fact well known to anyone who has tried to
finish promising research projects with inexperienced
students. Finally, who will be the next generation of
researchers? Academia has lost its appeal and our
struggles will hardly make our trainees want to follow
in our footsteps.
How did we get to this point?
There are two sides to this problem: stagnating funding,
that has to support an increasing number of excellent
labs, and a major shift in funding philosophy affecting
existing labs. In the past decades, biomedical research
yielded amazing results and the number of excellent
research groups exploded in Canada. Unimaginable
technical advances and the fast growth of the biotech
industry that supports experimental research widened
the scope and potential of research but also increased
expenses. Despite these factors, in the past years, fund-
ing stagnated, leading to plummeting funding rates and
a sharp fall in the value of individual grants. For ex-
ample, the latest transitional operating grant competition
of CIHR not only yielded an unprecedentedly low fund-
ing rate (below 15 %), but also saw a 27 % budget cut for
every awarded grant. This hit especially hard, since in
the past 2 years, we had only one competition per year
instead of the previous two. The decrease in inflation-
adjusted value of the Canadian Research and Development
expenditures is well demonstrated by Chakma et al. who
explored global trends in research funding during the
period of 2007–2012 [2]. Their data show a negative
growth in spending in Canada, the USA and Europe, which
was in sharp contrast to the huge growth in Asia,
most notably in China.
Along with stagnating funding, there is an ongoing
shift in the funding philosophy, as demonstrated by the
changing policies and funding priorities of CIHR and
Natural Sciences and Engineering Research Council
(NSERC). Especially problematic from my viewpoint is
the rapidly decreasing appreciation of curiosity-driven
fundamental research. The current trend rewards ap-
plied research and knowledge translation at the expense
of basic science and highly rates projects with potential
for commercialization, i.e. immediate ‘results’ and indus-
try relevance. In contrast, projects that aim for a better
understanding of fundamental mechanisms are increas-
ingly out of favour. A second trend is that large portions
of funding are directed towards selected research prior-
ities, further reducing funding for investigator-initiated
projects. As a result, applications that received lower
ranking from review panels are funded based on their
topic, with the danger that relevance takes precedent
over quality. Yet another trend is that money is directed
towards large labs and mega-projects, while starving
many smaller labs.
These shifts that tilt the balance of funding are based
on a few false beliefs. One such idea is that science is
slow in benefitting society because academic researchers
are reluctant to translate our knowledge. Accordingly,
only an emphasis on translational research will stop
scientists from doing ‘useless’ research for the sake of
research itself and speed the application of discoveries to
prevent and treat disease. However, the history of sci-
ence tells a different story, as leading scientists continue
to point out (e.g. [3–5]). In an excellent essay, David
Botstein of Princeton University argues that great ad-
vances in biomedical science are the direct result of
work by thousands of basic scientists whose primary
goal was to understand fundamental mechanisms of
biology [4]. It cannot be emphasized enough that basic
science generates the discoveries that form the basis for
translation. Thus, basic and translational science are
complementary. As a powerful editorial in the journal
Infection and Immunity puts it, ‘support for translational
research must be accompanied by a robust investment
in basic science, which provides the essential raw mater-
ial for translation and continues to represent humanity’s
best hope to meet a wide range of public health chal-
lenges’ [5]. Is it possible that the already accumulated
knowledge is adequate to solve all diseases if we put
more effort in translating? When considering this
question, we must remember that knowing facts does
not equal a deep and adequate understanding of
mechanisms, something that is a prerequisite for
successful translation. Thus, in the absence of good
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understanding of many processes in nature, the an-
swer to this question is no. Despite this, applications
aiming at mechanistic understanding of important pro-
cesses with no immediate disease relevance stand little
chance of funding.
A second false belief is that major steps can only come
from large projects, while smaller groups are useless and
not worth supporting. The truth is that discoveries can
come from anywhere, and only a broad base of well-
funded researchers can provide the environment and cul-
ture that will promote the creativity of and innovation by
all participants. Interestingly, the need of a wide base of
participants is well accepted in sports, where politicians
and the public agree that we must support a large popula-
tion of talents so some of them can reach the podium.
This requirement is true for science too, with the import-
ant difference that in research, there are no winners and
losers. Science does not move forward through large
breakthroughs generated by isolated research groups (win-
ners reaching the podium). Instead, main steps are due to
increments provided by years and years of painstaking,
slow work by many groups and slowly accumulating
knowledge achieved through a multitude of failures [6].
What about peer review?
Peer review was implemented to assure quality control
and fairness. Contrary to its intended role, our current
system is full of bias and greatly opposes risk taking and
outside-the-box thinking, major attributes of leading-edge
science. The problems of peer review were discussed in
detail by Wheeldon and Gordon [7]. The ultimate goal of
review is to select good projects with a high likelihood of
success. But there is an inherent contradiction: due to the
nature of scientific discovery, there is no good way of pre-
dicting which idea will work, which hypothesis will prove
correct. Contrary, the more novel an idea is, the higher
the chance that peer review will reject it as too risky.
Since funding decisions must be made; peer review
increasingly relies on ‘objective measures’ including pre-
liminary data and metrics to predict success. The re-
quirement to support all aspects of a proposal by
preliminary data is out of control. Significant portions of
existing grants are now spent on generating data for the
next grant. Due to the low funding rates, a large percent-
age of these data will never be further extended and
published. The cycle of writing and reviewing mostly
rejected applications leads to ballooning costs, money
spent on nothing. Gordon and Poulin convincingly dem-
onstrated how wasteful the peer review system is [8].
Using data from 2007, they estimated that the costs of
preparing an NSERC discovery grant and its rejection by
peer review ($40,000) exceeded that of giving every
qualified investigator directly an average baseline discov-
ery grant of $30,000. The amount of an average grant is
usually higher at other agencies, but the requirements
for expensive preliminary data are also more substantial.
As a consequence of falling success rates, the system is
clearly overwhelmed by the increasing number of appli-
cations, a large proportion of which are excellent and
would deserve funding. Reviewers are facing an almost
impossible task of selecting the few winners from the
large pool of excellent grants. They are often asked to
assess projects in which they are not content experts,
further increasing error.
To do the job, we are becoming overly critical, picky
and unreasonable. Overall, reviewing is becoming an
increasingly impossible and stressful job that unsurpris-
ingly quickly leads to burnout. For applicants, lack of
quality control and transparency in the review process is
a huge issue. There is no mechanism to protest against
mistakes and there is no accountability in the system.
Addressing issues raised by reviewers does not guarantee
a better ranking for the resubmitted grant, leading to
endless cycles of resubmissions.
Since prior productivity is viewed as a good indicator
for future success, much emphasis is put on this aspect
when assessing applicants. For this, committees increas-
ingly rely on metrics, but the use of these is problematic.
This is a larger topic that I cannot address here in detail, so
I will only mention one example: journal impact factors
were not designed for the purpose of assessing the quality
of applicants’ papers. The Declaration on Research Assess-
ments (DORA) that was endorsed by a multitude of leading
scientists and scientific organizations intends to reduce
biases and inaccuracies when evaluating research by halting
the practice of correlating the journal impact factor to the
merits of a specific scientist’s contributions [9].
What are the solutions?
There are no obvious, easy solutions for such a complex
issue as improving the funding system. CIHR is cur-
rently undergoing a major overhaul, and other agencies,
including the Kidney Foundation of Canada, are also
changing their application process to improve peer re-
view. It is too early to know the effects of these changes.
An honest assessment and a better conversation between
agencies and the research community will be vital. Im-
portantly, improving the system will require not only
more money, but also a rethinking of funding philosophy
and peer review. Reform should aim at reducing the
counterproductive struggle for funding. Increased funding
security for some well-established researchers through the
new CIHR foundation scheme is a good step. But with its
long evaluation times and low funding rates, it leaves
many outstanding applicants in an unfair funding limbo
for extended periods of time. Without better funding for
the project scheme, the system will also leave a large
portion of labs unfunded. The balance also appears to
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be tilting further towards translation at the expense of dis-
covery research, a trend that will ultimately be detrimental
for innovation. Finally, eliminating face-to-face meetings
will save money, but will also remove an important quality
control step and thus will reduce fairness.
One possible solution could be to decrease the reliance
of researchers on the grant system. Support provided by
institutions could increase funding security. Quality
control can be maintained by the careful selection process
through which institutes hire the best researchers. Funding
researchers and not specific projects can promote
risk taking.
In summary, supporting a broad variety of research
including basic and translational projects and a large co-
hort of committed researchers is of utmost importance
and is the best way to generate an environment of
innovation and translation, something that will surely
benefit all Canadians.
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